Coston McIsaac & Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Buy
313
+4
+1% +$293 ﹤0.01% 478
2026
Q1
$23K Buy
309
+3
+1% +$216 0.01% 440
2025
Q4
$19K Buy
+306
New +$18.9K ﹤0.01% 477
2023
Q2
Sell
-30
Closed -$2K 780
2023
Q1
$2K Buy
+30
New +$2.58K ﹤0.01% 682

Other funds holding EMN

Coston McIsaac & Partners's EMN Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Eastman Chemical (EMN) stake by 1.3% in Q2 2026, buying an estimated $293 and bringing the position to 313 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

Coston McIsaac & Partners first reported a position in EMN in Q1 2023 and has held it in 4 quarters since. The position peaked at $23K in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Coston McIsaac & Partners held 313 shares of Eastman Chemical worth $20K as of Q2 2026.
  • Coston McIsaac & Partners bought 4 Eastman Chemical shares in Q2 2026, an estimated $293.
  • Eastman Chemical made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #478 holding.
  • Coston McIsaac & Partners first reported a position in Eastman Chemical in Q1 2023 and has held it in 4 quarters since.
  • Coston McIsaac & Partners's Eastman Chemical position peaked at $23K in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.